相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor
Kar Lok Kong et al.
GUT (2012)
Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
A. Bergamaschi et al.
ONCOGENE (2012)
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
L. Sun et al.
ONCOGENE (2012)
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
Francesca M. Buffa et al.
CANCER RESEARCH (2011)
Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition
Xiaoyan Li et al.
CANCER SCIENCE (2011)
Epigenetic regulation of microRNA-375 and its role in melanoma development in humans
Joseph Mazar et al.
FEBS LETTERS (2011)
miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
Espen Enerly et al.
PLOS ONE (2011)
MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3ζ
Yoshiyuki Tsukamoto et al.
CANCER RESEARCH (2010)
Epigenetically Deregulated microRNA-375 Is Involved in a Positive Feedback Loop with Estrogen Receptor α in Breast Cancer Cells
Pedro de Souza Rocha Simonini et al.
CANCER RESEARCH (2010)
Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance
Oezguer Sahin et al.
BMC SYSTEMS BIOLOGY (2009)
MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
Guohong Hu et al.
CANCER CELL (2009)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells
Mi Ra Kim et al.
CANCER SCIENCE (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Epithelial mesenchymal transition traits in human breast cancer cell lines
T. Blick et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
Yannick Ladeiro et al.
HEPATOLOGY (2008)
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Tyler E. Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Modelling breast cancer: one size does not fit all
Tracy Vargo-Gogola et al.
NATURE REVIEWS CANCER (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
Stephen Hiscox et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation
S Hiscox et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
A Eger et al.
ONCOGENE (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
Long-term exposure to tamoxifen induces hypersensitivity to estradiol
LM Berstein et al.
CLINICAL CANCER RESEARCH (2004)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells
S Cariou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
